Novartis Plans Share Buyback via Swiss Exchange

Novartis Pharmaceuticals has announced plans to repurchase up to 10% of its registered shares through an independent trading channel on the Swiss Stock Exchange over the next three years. According to Jin10, this strategic move aims to enhance shareholder value and optimize capital structure. The company has not disclosed further details regarding the timing or financial implications of the buyback program.